Literature DB >> 3124163

Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.

A J Stoessl1, C T Dourish, S D Iversen.   

Abstract

Apomorphine-induced yawning was studied in male rats with bilateral 6-hydroxydopamine lesions of the substantia nigra. Apomorphine 10, 20 and 50 micrograms/kg SC induced dose-dependent yawning in unoperated controls and animals with sham lesions. In the lesioned animals (in which the mean striatal dopamine depletion was 67%), the maximum yawning response rate was greatly attenuated with no evidence that the dose response curve was shifted in either direction. Furthermore, blockade of yawning in the lesioned animals was not simply due to suppression by other stereotyped behaviours, since there was no evidence of increased sniffing or chewing in these animals. These data provide further support for the hypothesis that apomorphine-induced yawning is mediated by dopamine autoreceptors and requires intact nigrostriatal projections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124163     DOI: 10.1007/bf00187253

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  Yawning.

Authors:  J BARBIZET
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-08       Impact factor: 10.154

2.  Behavioural changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte-stimulating hormone.

Authors:  W FERRARI
Journal:  Nature       Date:  1958-03-29       Impact factor: 49.962

3.  Drugs affecting dopamine neurons and yawning behavior.

Authors:  E Mogilnicka; V Klimek
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

4.  On the use of lesions of afferents to localize neurotransmitter receptor sites in the striatum.

Authors:  T Hattori; H C Fibiger
Journal:  Brain Res       Date:  1982-04-22       Impact factor: 3.252

5.  Effects of apomorphine, TL-99 and 3-PPP on yawning in rats.

Authors:  E Mogilnicka; C G Boissard; A Delini-Stula
Journal:  Neuropharmacology       Date:  1984-01       Impact factor: 5.250

6.  Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.

Authors:  R Longoni; L Spina; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-02-10       Impact factor: 4.432

7.  Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.

Authors:  G Serra; M Collu; G L Gessa
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

Authors:  M T Pugh; K M O'Boyle; A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Apomorphine-induced penile erection and yawning: site of action in brain.

Authors:  M R Melis; A Argiolas; G L Gessa
Journal:  Brain Res       Date:  1987-07-07       Impact factor: 3.252

10.  Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.

Authors:  C T Dourish; S J Cooper; S R Philips
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  8 in total

1.  Effects of GABAergic drugs on physostigmine-induced yawning in rats.

Authors:  M R Zarrindast; V Toloui; B Hashemi
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.

Authors:  M R Zarrindast; A Jamshidzadeh
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

4.  Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats.

Authors:  P Protais; M Windsor; E Mocaër; E Comoy
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

5.  The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity.

Authors:  A Bourson; A J Gower; A K Mir; P C Moser
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

6.  Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats.

Authors:  M Poncelet; J Souilhac; C Gueudet; J P Terranova; D Gully; G Le Fur; P Soubrié
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

7.  Role of dopamine receptors in the dual effect of naloxone on quinpirole-induced yawning in morphine pretreated rats.

Authors:  A Zharkovsky; J Moisio; T Kivastik; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

8.  A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT2C Receptors in Rats: Implication of the Subthalamic Nucleus.

Authors:  Mélanie Lagière; Marion Bosc; Sara Whitestone; Abdelhamid Benazzouz; Abdeslam Chagraoui; Mark J Millan; Philippe De Deurwaerdère
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.